Strategy
It's a pattern we see often: a manufacturer has real success in one Swiss canton — say, a strong reference client in Zürich — and assumes the next step is simply "more of the same" everywhere else. Six months later, momentum has stalled, and the team isn't sure why. The answer is almost always the same: what worked in Zürich was never a Swiss strategy. It was a Zürich strategy.
Regional markets, not regional flavors of one market
It's tempting to treat German-speaking, French-speaking, and Italian-speaking Switzerland as the same market with different labels. They aren't. Procurement committees in each region operate within different professional networks, reference different peer institutions, and — critically — trust different messengers. A introduction that works because of a shared connection in Zürich has no equivalent weight in Geneva.
Budget cycles and priorities don't align nationally
Because purchasing decisions are made at the hospital or hospital-group level, budget cycles and clinical priorities vary independently of any national calendar. A canton investing heavily in one clinical area this year may have entirely different priorities next year — and that timing rarely matches up neatly across regions.
What differentiation actually looks like
- Materials and conversations in the region's working language — not just translated collateral.
- Separate relationship-building tracks for each linguistic region you prioritize, rather than one national campaign.
- A prioritized sequence of cantons based on where your specific product category has the strongest fit — not the largest population.
This is precisely what a Market Validation engagement is designed to produce: a realistic, canton-by-canton sequence rather than a single flat rollout plan.